Medical care of childhood leukaemia

PubMed

Insights

Local hospitals providing optimal treatment regimens for childhood leukemia match survival rates of specialized centers. Improving local care is key, not concentrating all leukemia treatment in a few facilities.

Area of Science:

  • Pediatric Oncology
  • Health Services Research

Background:

  • Childhood leukemia treatment is complex and resource-intensive.
  • Care delivery models vary, with some children treated locally and others at specialized centers.
  • Evaluating the effectiveness of different care settings is crucial for optimizing outcomes.

Purpose of the Study:

  • To compare the medical care and outcomes for children with leukemia treated at local hospitals versus specialized centers.
  • To assess survival rates, social, psychological, satisfaction, and cost outcomes across different treatment settings.
  • To inform regional healthcare policies for childhood leukemia management.

Main Methods:

  • Review of medical care for a population-based sample of children with leukemia 2-3 years post-diagnosis.
  • Categorization of local hospitals based on therapeutic regimens used.
  • Comparison of outcomes between children treated at local hospitals and specialized leukemia treatment centers.

Main Results:

  • Over half of children received treatment at local hospitals; the remainder were referred to specialized centers.
  • Survival rates for children receiving optimal regimens at local hospitals were comparable to those at two of three specialized centers.
  • No significant differences were observed in social, psychological, satisfaction, or cost outcomes between the groups.

Conclusions:

  • Improving therapeutic regimens at local hospitals is a viable strategy for childhood leukemia care.
  • Regional policies should focus on enhancing local treatment capabilities rather than solely concentrating care at specialized centers.
  • Decentralized, high-quality local care can achieve outcomes equivalent to specialized centers for childhood leukemia.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...